Urology resident @UCSFUrology, Cancer Biologist, Dancer/Artist. Alumni @Harvard BA '11 @Dartmouth PhD ‘18 @GeiselMed MD ‘20
San Francisco, CA
Joined September 2010
- Tweets359
- Following604
- Followers618
- Likes1.8K
It’s been an honor and privilege to welcome @DanLinMD, Professor and Chair at @uwurology, as the Emil Tanagho Visiting Professor at @UCSFUrology. Thank you for all of the wonderful insights about all things PCa and surveillance, and for spending the afternoon with the residents!
Kevin Shee, MD, PhD retweeted
The Future Urologic Oncologists program, @UroOnc will take place, July 24-26 in Indianapolis.
PGY2/3s, learn from the exec board + members what the SUO provides; fellowship, community, leadership opportunities + friendships.
Sign up soon. App deadline is approaching.
Kevin Shee, MD, PhD retweeted
🚨 JUST PUBLISHED in @EUplatinum
Updated meta-analysis (40 studies, 9,400+ patients) shows #bpMRI is NONINFERIOR to #mpMRI for clinically significant #PCa
🌟 First to include #PRIME trial data; proud to be part of this 🌏 collaboration
📄 Read HERE: sciencedirect.com/science/ar…
Kevin Shee, MD, PhD retweeted
Integrating genomic prognostic and hallmark signatures from #Decipher GRID to predict adverse outcomes in men on active surveillance for #ProstateCancer. Presented by @KShee11 @UCSFUrology. #GU26 written coverage by @chavarriagaj @PSH_Urology > bit.ly/47h7VBp @ASCO
Kevin Shee, MD, PhD retweeted
Another terrific one from @KShee11: GG2 is highly heterogeneous and many of these cases can continue to be followed safely with #activesurveillance. Caution re: high PSAD and PI-RADS 5. And definitely consider unfavorable histology differently. #GU26 @ucsfurology
Kevin Shee, MD, PhD retweeted
The inimitable @KShee11 @ucsfurology with one of his multiple high-impact #GU26 posters: Decipher GRID analysis of predictors of degeneration to unfavorable histology in #prostatecancer #activesurveillance
Kevin Shee, MD, PhD retweeted
🧬 Active surveillance (AS) ≠ one-size-fits-all for #ProstateCancer
🚨 New @EurUrolOncol data on Genomic Classifier (GC) in AS:
🔺High GC (≥0.6) → ↑ risk of major upgrading (GG≥3)
🔬↑ risk of unfavorable histology (IDC / cribriform)
🎯👀 Signals who may need closer surveillance, not overtreatment
🧠Risk-adapted AS matters
🔗shorturl.at/YHtQf
@dr_coops @KShee11 @Decipher_VCYT @Davicioni @PCFnews @UrologyTimes @renalandurology @MRoupret
Also, a mentorship lineage that includes many giants and rising stars in the @UroOnc community! His impact has and will continue to transform prostate cancer management in the future. So fortunate to have @pcarroll_ as a mentor and to be a part of @UCSFUrology. #SUO2025
Standing ovation for @pcarroll_ recipient of this year’s Huggins medal #SUO2025. Astounding vision, intellect, and impact on the field and our patients. Congratulations.
#SUO2025 @UCSFUrology @UCSFCancer
Kevin Shee, MD, PhD retweeted
Integrating genomic prognostic and hallmark signatures from Decipher GRID to predict adverse outcomes in men on active surveillance for #ProstateCancer. Presented by @KShee11 @UCSFUrology. #WSAUA25 written coverage by @zklaassen_md @GACancerCenter > bit.ly/43P7Ov4 @auawest
Kevin Shee, MD, PhD retweeted
This year's @AmerUrological annual meeting featured many of our @UCSFUrology experts, including @ben_breyer, @drcoops, @SamWashUro, @KShee11, @SimaPorten, @haognguyen & @mvankuikenmd. Learn more about their leading-edge research: ucsfh.org/3IeqooR #AUA2025
Kevin Shee, MD, PhD retweeted
Dr. Cooperberg receives ASPI’s 2025 Special Award for Patient Advocacy for leading a successful campaign to restore Active Surveillance in prostate cancer guidelines. youtu.be/ZHQIkIze6k8?si=jBMK…
Check out @dr_coops presentation on AS:
youtu.be/ev1WcQ1Ucic?si=LII9…
Kevin Shee, MD, PhD retweeted
Congratulations to Dr. Porten on her appointment as Chief of Urologic Oncology! A role that recognizes her exceptional clinical expertise, research leadership, and long-standing commitment to advancing care for patients with genitourinary cancer.
urology.ucsf.edu/news/all/20…
Kevin Shee, MD, PhD retweeted
Excited for the next crop of urology hopefuls!!
We are an academically-focused program that will provide strong surgical skills, research and leadership opportunities, a chance to work with all specialties and diverse hospital systems, and above all a family to become a part of!
📢Save-the-date & join us for the UCSF Urology's Virtual Residency Open House Event! See event details below.
🗓️Wednesday, July 16th, 2025
⏰5:00pm - 6:00pm PST
Zoom Registration Link: ucsf.zoom.us/meeting/registe……
Can't wait to see you all there!
So thrilled to stay in the Bay to continue the research momentum I’ve built. Thanks to @pcarroll_ @SimaPorten @Uro_Max @haognguyen @dr_coops @SamWashUro @anobelodisho @CChuMD @MeeraChappidi for the support!
In @EurUrolFocus, we show that grade group 3 (GG3) prostate cancers are heterogeneous. Unfavorable histology (EC or IDC) was strongly associated with recurrence after surgery, independent of % pattern 4 and CAPRA-S, and may improve risk stratification. pubmed.ncbi.nlm.nih.gov/4037….
Congratulations to one of my mentors @UCSFUrology @haognguyen on his paper in @Cancer_Cell! This groundbreaking work on Zotatifin and its role in targeting protein synthesis to kill prostate cancer cells is a major step forward in #prostatecancer research! @UCSFCancer @UCSF
Grateful to @pcarroll_ @UCSFUrology for sending me to present my work at #EAU25 and @SimaPorten for showing me around! Huge thanks to @Uroweb for an outstanding conference and @EUplatinum for getting us in Santiago Bernabéu Stadium! Made friends and future colleagues for life!
Incredible state-of-the-art talk by @UCSFUrology @SimaPorten at #EAU25 on TARs, the novel bladder drug delivery system with great initial trial results. Loved her mnemonic for the Sunrise trials: odd numbers (1, 3, 5) for NMIBC and even (2, 4) for MIBC — simple and brilliant!
Kevin Shee, MD, PhD retweeted
Elevated PSA Link to Higher Recurrence Risk in Intermediate-Risk #ProstateCancer @KShee11 @UCSFUrology @ASCO #GU25 curetoday.com/view/elevated-…
